[HTML][HTML] Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer …
K Pillai, AH Mekkawy, J Akhter, S Badar… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Current systemic dosages of chemotherapeutic drugs such as gemcitabine, 5-FU, cisplatin,
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …
[HTML][HTML] Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy
A Amini, S Masoumi-Moghaddam, A Ehteda… - Journal of Experimental …, 2014 - Springer
Background Bromelain and N-acetylcysteine are two natural, sulfhydryl-containing
compounds with good safety profiles which have been investigated for their benefits and …
compounds with good safety profiles which have been investigated for their benefits and …
[HTML][HTML] Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition in vivo in human colon cancer cell line LS174T
AH Mekkawy, K Pillai, S Badar, J Akhter… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The combinations of Bromelain and Acetylcysteine (BromAc®) with cytotoxics such as
Gemcitabine, 5-Fluorouracil or Oxaliplatin have shown a dramatic reduction in IC50 values …
Gemcitabine, 5-Fluorouracil or Oxaliplatin have shown a dramatic reduction in IC50 values …
[HTML][HTML] Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells
A Amini, S Masoumi-Moghaddam… - American journal of …, 2016 - ncbi.nlm.nih.gov
Intraperitoneal chemotherapy together with cytoreductive surgery is the standard of care for
a number of peritoneal surface malignancies. However, this approach fails to maintain the …
a number of peritoneal surface malignancies. However, this approach fails to maintain the …
Supraadditive effect of 2′, 2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
S Faivre, E Raymond, JM Woynarowski… - Cancer chemotherapy …, 1999 - Springer
Purpose: This study assessed the cytotoxic effects of the nucleoside analog gemcitabine in
combination with the diaminocyclohexane platinum compound oxaliplatin. Methods: Growth …
combination with the diaminocyclohexane platinum compound oxaliplatin. Methods: Growth …
Zoledronic Acid (Zometa®) Enhances the Cytotoxic Effect of Gemcitabine and Fluvastatin: In vitro Isobologram Studies with Conventional and Nonconventional …
DR Budman, A Calabro - Oncology, 2006 - karger.com
Objectives: To identify synergistic combinations of clinically available agents with zoledronic
acid which would enhance antitumor activity as measured by median effect isobologram …
acid which would enhance antitumor activity as measured by median effect isobologram …
[HTML][HTML] Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer
VL Damaraju, DY Bouffard, CKW Wong, ML Clarke… - BMC cancer, 2007 - Springer
Background Gemcitabine, a deoxycytidine nucleoside analog, is the current standard
chemotherapy used as first-line treatment for patients with locally advanced or metastatic …
chemotherapy used as first-line treatment for patients with locally advanced or metastatic …
[HTML][HTML] Interaction between cisplatin, 5-fluorouracil and vincristine on human hepatoma cell line (7721)
WX Tang, PY Cheng, YP Luo… - World Journal of …, 1998 - ncbi.nlm.nih.gov
AIM: To evaluate the killing effects of CDDP, 5-Fu and VCR on human hepaoma cell line
(7721). METHODS: The median-effect principle was used. RESULTS: Killing effects of the …
(7721). METHODS: The median-effect principle was used. RESULTS: Killing effects of the …
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation
Combination chemotherapy is commonly used to treat late stage cancer; however, treatment
is often limited by systemic toxicity. Optimizing drug ratio and schedule can improve drug …
is often limited by systemic toxicity. Optimizing drug ratio and schedule can improve drug …
Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives
K Chobotova, AB Vernallis, FAA Majid - Cancer letters, 2010 - Elsevier
The medicinal qualities of pineapple are recognized in many traditions in South America,
China and Southeast Asia. These qualities are attributed to bromelain, a 95%-mixture of …
China and Southeast Asia. These qualities are attributed to bromelain, a 95%-mixture of …
相关搜索
- chemotherapeutic agents cancer cells
- tumor inhibition bromelain and acetylcysteine
- survival of gastrointestinal cancer cells
- cell lines combination with oxaliplatin
- cell lines supraadditive effect
- synergistic activity pancreatic cancer
- supraadditive effect combination with oxaliplatin
- combination therapy cancer cells
- proliferation and survival cancer cells